Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James B. Weissman currently holds 5,268 shares of Dicerna Pharmaceuticals Inc (DRNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James B. Weissman has been a net seller of DRNA stock. They have purchased $31.4K and sold $5.7M worth of shares.
James B. Weissman's most recent insider trade was on Jul 24, 2024, when they sold 5,268 shares at $0.00 per share.
James B. Weissman serves as Executive at Dicerna Pharmaceuticals Inc (DRNA). They have executed 72 insider transactions totaling $5.7M over their tenure at the company.
James B. Weissman holds the position of Executive at Dicerna Pharmaceuticals Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
James B. Weissman has shown a selling trading pattern, with $31.4K in total purchases and $5.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James B. Weissman was on Jul 6, 2021, when they sold $1.2M worth of DRNA shares. This transaction involved 30,000 shares at $39.09 per share.
James B. Weissman currently owns 5,268 shares of Dicerna Pharmaceuticals Inc (DRNA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James B. Weissman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James B. Weissman has 72 Form 4 filings on record as an insider at Dicerna Pharmaceuticals Inc.
Set alerts for James B. Weissman and 40,000+ other insiders.